Kanagawa, Japan

Tatsuo Yanagisawa



Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Kanagawa, JP (2014)
  • Yokohama, JP (2015)
  • Saitama, JP (2021 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Tatsuo Yanagisawa

Introduction

Tatsuo Yanagisawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to his name, Yanagisawa's work has advanced the understanding and application of antibodies in medical science.

Latest Patents

Yanagisawa's latest patents focus on antibodies with non-natural amino acids introduced therein. These inventions relate to a monoclonal antibody or antibody fragment that includes at least one lysine derivative in the constant region of the human IgG antibody. The patents also cover modified antibodies, nucleic acids encoding these antibodies, vectors containing the nucleic acids, and methods for producing the antibodies. This innovative work has the potential to enhance therapeutic applications in various medical fields.

Career Highlights

Throughout his career, Yanagisawa has worked with prominent companies such as Riken Corporation and Kyowa Kirin Co., Ltd. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Some of his notable coworkers include Kensaku Sakamoto and Shigeyuki Yokoyama. Their collaborative efforts have contributed to the advancement of antibody research and development.

Conclusion

Tatsuo Yanagisawa's contributions to the field of biotechnology through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic solutions in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…